Management of membranous nephropathy: when and what for treatment.
Cattran
Daniel
D
Toronto General Research Institute, University Health Network, Toronto General Hospital, NCSB 11-1256, 585 University Avenue, Toronto, Ontario M5G 2N2, Canada. daniel.cattran@uhn.on.ca
D015433:Glomerulonephritis, Membranous / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012307:Risk Factors
D007166:Immunosuppressive Agents